Franklin Resources’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	+90,330	New	+$697K	﹤0.01%	2386
2025 Q2	–	Sell	-38,926	Closed	-$179K	–	3138
2025 Q1	$179K	Buy	38,926 +19,146	+97%	+$89.2K	﹤0.01%	2718
2024 Q4	$94.7K	Sell	19,780 -35,446	-64%	-$170K	﹤0.01%	2757
2024 Q3	$266K	Buy	55,226 +4,449	+9%	+$23.9K	﹤0.01%	2535
2024 Q2	$287K	Buy	50,777 +31,845	+168%	+$164K	﹤0.01%	2445
2024 Q1	$77.8K	Buy	18,932 +791	+4%	+$3.17K	﹤0.01%	2735
2023 Q4	$76.6K	Sell	18,141 -42,751	-70%	-$172K	﹤0.01%	2496
2023 Q3	$263K	Sell	60,892 -137,431	-69%	-$764K	﹤0.01%	2208
2023 Q2	$1.31M	Buy	198,323 +35,572	+22%	+$228K	﹤0.01%	1557
2023 Q1	$1.11M	Buy	162,751 +840	+0.5%	+$5.91K	﹤0.01%	1479
2022 Q4	$1.2M	Buy	161,911 +519	+0.3%	+$5.05K	﹤0.01%	1479
2022 Q3	$1.59M	Buy	161,392 +80,777	+100%	+$853K	﹤0.01%	1410
2022 Q2	$880K	Buy	80,615 +48,864	+154%	+$506K	﹤0.01%	1565
2022 Q1	$359K	Hold	31,751	–	–	﹤0.01%	1947
2021 Q4	$498K	Sell	31,751 -146	-0.5%	-$2.54K	﹤0.01%	1907
2021 Q3	$546K	Buy	+31,897	New	+$559K	﹤0.01%	1852